{"id":"W4379347570","doi":"10.1017/cjn.2023.148","title":"P.044 Efficacy, safety, and tolerability of efgartigimod in AChR-Ab– patients with Generalized Myasthenia Gravis: interim analysis of ADAPT/ADAPT+","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Myasthenia gravis; Tolerability; Medicine; Placebo; Interim analysis; Internal medicine; Population; Acetylcholine receptor; Clinical endpoint; Adverse effect; Gastroenterology; Clinical trial; Receptor; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003689875,0.0007254619,0.001339915,0.0003179201,0.0002790497,0.0007927661,0.000455839,0.0003662874,0.00347872],"category_scores_gemma":[0.001417095,0.0003014193,0.002340638,0.0003556494,0.0004257659,0.0005821494,0.0004672098,0.001103,0.0006428295],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000505766,"about_ca_system_score_gemma":0.0008602581,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003994266,"about_ca_topic_score_gemma":0.0007342037,"domain_scores_codex":[0.9990487,0.0004251142,0.0000673413,0.0001341719,0.0001690355,0.0001557173],"domain_scores_gemma":[0.9987399,0.0003242861,0.0003722543,0.0002509012,0.0001376544,0.0001750546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7295146,0.00904061,0.1510135,0.0004527337,0.008238991,0.0002774532,0.0001102981,0.003718871,0.01653391,0.0001851382,0.005345851,0.07556809],"study_design_scores_gemma":[0.1053401,0.3461094,0.5145936,0.00008952419,0.008723213,0.0006022838,0.0001168,0.005291658,0.01043193,0.0004925385,0.00813419,0.00007485791],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991042,0.0006120156,0.0007416005,0.00009713758,0.00003579023,0.0008562552,0.0041845,0.00006390097,0.0023667],"genre_scores_gemma":[0.9854888,0.0002439617,0.001512139,0.0002529418,0.00007015337,0.001342485,0.008571233,0.00003257666,0.002485729],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003689875,"threshold_uncertainty_score":0.01951414,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03128327708383018,"score_gpt":0.2772028115815919,"score_spread":0.2459195344977617,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}